Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-011666
Filing Date
2024-08-09
Accepted
2024-08-08 20:28:12
Documents
84
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ntra-20240630x10q.htm   iXBRL 10-Q 2213544
2 EX-10.1 ntra-20240630xex10d1.htm EX-10.1 160135
3 EX-31.1 ntra-20240630xex31d1.htm EX-31.1 13832
4 EX-31.2 ntra-20240630xex31d2.htm EX-31.2 14894
5 EX-32.1 ntra-20240630xex32d1.htm EX-32.1 10378
6 EX-32.2 ntra-20240630xex32d2.htm EX-32.2 10657
  Complete submission text file 0001558370-24-011666.txt   10273148

Data Files

Seq Description Document Type Size
7 EX-101.SCH ntra-20240630.xsd EX-101.SCH 64098
8 EX-101.CAL ntra-20240630_cal.xml EX-101.CAL 64234
9 EX-101.DEF ntra-20240630_def.xml EX-101.DEF 291395
10 EX-101.LAB ntra-20240630_lab.xml EX-101.LAB 576501
11 EX-101.PRE ntra-20240630_pre.xml EX-101.PRE 450074
87 EXTRACTED XBRL INSTANCE DOCUMENT ntra-20240630x10q_htm.xml XML 1965712
Mailing Address 13011 MCCALLEN PASS BUILDING A SUITE 100 AUSTIN TX 78753
Business Address 13011 MCCALLEN PASS BUILDING A SUITE 100 AUSTIN TX 78753 650-249-9090
Natera, Inc. (Filer) CIK: 0001604821 (see all company filings)

EIN.: 010894487 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37478 | Film No.: 241190108
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)